These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 37860064)

  • 1. Elucidating the role played by bone marrow in visceral leishmaniasis.
    Veras PST; de Santana MBR; Brodskyn CI; Fraga DBM; Solcà MS; De Menezes JPB; Leite BMM; Teixeira HMP
    Front Cell Infect Microbiol; 2023; 13():1261074. PubMed ID: 37860064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical forms of canine visceral Leishmaniasis in naturally Leishmania infantum-infected dogs and related myelogram and hemogram changes.
    Nicolato Rde C; de Abreu RT; Roatt BM; Aguiar-Soares RD; Reis LE; Carvalho Md; Carneiro CM; Giunchetti RC; Bouillet LE; Lemos DS; Coura-Vital W; Reis AB
    PLoS One; 2013; 8(12):e82947. PubMed ID: 24376612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Geographic distribution and spatial analysis of
    Mohebali M; Moradi-Asl E; Rassi Y
    J Vector Borne Dis; 2018; 55(3):173-183. PubMed ID: 30618442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic and compartmentalized immune response in canine visceral leishmaniasis.
    Reis AB; Martins-Filho OA; Teixeira-Carvalho A; Giunchetti RC; Carneiro CM; Mayrink W; Tafuri WL; Corrêa-Oliveira R
    Vet Immunol Immunopathol; 2009 Mar; 128(1-3):87-95. PubMed ID: 19054576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
    Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
    Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interpretation of laboratory data during cryptic leishmaniasis in dog].
    Gravino AE
    Parassitologia; 2004 Jun; 46(1-2):227-9. PubMed ID: 15305723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new Leishmania hypothetical protein can be used for accurate serodiagnosis of canine and human visceral leishmaniasis and as a potential prognostic marker for human disease.
    Machado AS; Ramos FF; Santos TTO; Costa LE; Ludolf F; Lage DP; Bandeira RS; Tavares GSV; Oliveira-da-Silva JA; Steiner BT; Chaves AT; Oliveira JS; Chávez-Fumagalli MA; de Magalhães-Soares DF; Silveira JAG; Duarte MC; Machado-de-Ávila RA; Lyon S; Gonçalves DU; Caligiorne RB; Coelho EAF
    Exp Parasitol; 2020 Sep; 216():107941. PubMed ID: 32622940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of Leishmania infantum infection in dogs living in an area of canine leishmaniasis endemicity using PCR on several tissues and serology.
    Solano-Gallego L; Morell P; Arboix M; Alberola J; Ferrer L
    J Clin Microbiol; 2001 Feb; 39(2):560-3. PubMed ID: 11158106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The spread of visceral leishmaniasis in Brazil: the first canine cases described in Ji-Paraná, Rondônia, Brazil.
    Almeida AP; Pereira Júnior AM; Paulo PFM; Pinto AMM; Boroviec BB; Viana GA; Freitas MTS; Fuverki RBN; Ferreira RGM; Medeiros JF
    Rev Bras Parasitol Vet; 2021; 30(4):e011021. PubMed ID: 34852154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First report of imported canine visceral leishmaniasis cases in Panama, Central America: Public health implications.
    Terrero I; Pineda V; Vásquez V; Miranda A; Saldaña A; Calzada JE; González K
    Vet Parasitol Reg Stud Reports; 2022 Jul; 32():100745. PubMed ID: 35725108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiological aspects of vector, parasite, and domestic reservoir in areas of recent transmission and no reported human cases of visceral leishmaniasis in Brazil.
    Lara-Silva Fde O; Michalsky ÉM; Fortes-Dias CL; Fiuza Vde O; Pessanha JE; Regina-Silva S; de Avelar DM; Silva MA; Lima AC; da Costa AJ; Machado-Coelho GL; Dias ES
    Acta Trop; 2015 Aug; 148():128-36. PubMed ID: 25882769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct antigen recognition pattern during zoonotic visceral leishmaniasis in humans and dogs.
    Goto Y; Howard RF; Bhatia A; Trigo J; Nakatani M; Netto EM; Reed SG
    Vet Parasitol; 2009 Mar; 160(3-4):215-20. PubMed ID: 19059724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A canine leishmaniasis pilot survey in an emerging focus of visceral leishmaniasis: Posadas (Misiones, Argentina).
    Cruz I; Acosta L; Gutiérrez MN; Nieto J; Cañavate C; Deschutter J; Bornay-Llinares FJ
    BMC Infect Dis; 2010 Dec; 10():342. PubMed ID: 21122107
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    de Macedo GC; Barreto WTG; de Oliveira CE; Santos FM; Porfírio GEO; Xavier SCDC; Alves FM; da Silva AR; de Andrade GB; Rucco AC; de Assis WO; Jansen AM; Roque ALR; Herrera HM
    Front Cell Infect Microbiol; 2022; 12():1050339. PubMed ID: 36710973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Overview of Immunotherapeutic Approaches Against Canine Visceral Leishmaniasis: What Has Been Tested on Dogs and a New Perspective on Improving Treatment Efficacy.
    Gonçalves AAM; Leite JC; Resende LA; Mariano RMDS; Silveira P; Melo-Júnior OAO; Ribeiro HS; de Oliveira DS; Soares DF; Santos TAP; Marques AF; Galdino AS; Martins-Filho OA; Dutra WO; da Silveira-Lemos D; Giunchetti RC
    Front Cell Infect Microbiol; 2019; 9():427. PubMed ID: 31921703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of a real time PCR for leishmaniasis diagnosis using a L. (L.) infantum hypothetical protein as target in canine samples.
    Colombo FA; Pereira-Chioccola VL; Meira Cda S; Motoie G; Gava R; Hiramoto RM; de Almeida ME; da Silva AJ; Cutolo AA; Menz I
    Exp Parasitol; 2015 Oct; 157():156-62. PubMed ID: 26297683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Leishmania-specific hypothetical protein expressed in both promastigote and amastigote stages of Leishmania infantum employed for the serodiagnosis of, and as a vaccine candidate against, visceral leishmaniasis.
    Martins VT; Duarte MC; Chávez-Fumagalli MA; Menezes-Souza D; Coelho CS; de Magalhães-Soares DF; Fernandes AP; Soto M; Tavares CA; Coelho EA
    Parasit Vectors; 2015 Jul; 8():363. PubMed ID: 26160291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Canine visceral leishmaniasis in area with recent Leishmania transmission: prevalence, diagnosis, and molecular identification of the infecting species.
    Lopes JV; Michalsky ÉM; Pereira NCL; Paula AJV; Souza AGM; Pinheiro LC; Lima ACVMDR; Avelar DM; França-Silva JC; Lanzetta VAS; Melo J; Fortes-Dias CL; Dias ES
    Rev Soc Bras Med Trop; 2020; 53():e20200141. PubMed ID: 32935783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a municipality as free of canine visceral leishmaniasis in the context of One Health.
    Osaki SC; Bregonde RB; Dahm V; Pereira P; Postai C; Campos MP; Figueiredo FB
    Rev Bras Parasitol Vet; 2021; 30(2):e026720. PubMed ID: 34133617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of miltefosine to treat canine visceral leishmaniasis caused by Leishmania infantum in Brazil.
    Dos Santos Nogueira F; Avino VC; Galvis-Ovallos F; Pereira-Chioccola VL; Moreira MAB; Romariz APPL; Molla LM; Menz I
    Parasit Vectors; 2019 Feb; 12(1):79. PubMed ID: 30736866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.